Scientists discover how cancers generate muscle-like contractions to spread around the body

August 16, 2011 in Cancer

Cancer Research UK-funded scientists have discovered that a protein called JAK triggers contractions in tumors which allows cancer cells to squeeze though tiny spaces and spread, in research published in Cancer Cell today.

The collaboration of scientists from The Institute of Cancer Research (ICR) in London together with scientists in France at and the University of Nice showed that when a called JAK becomes ‘switched on’ it leads to muscle-like in cells to generate the force that require to move.

The finding raises the possibility that drugs targeting JAK could potentially stop the spread of tumours, called metastasis, which is responsible for 90 per cent of cancer-related deaths.

Tumors consist of cancer cells, tumour-associated and scaffolding that sticks everything together called the cell matrix. Cancer cells spread by moving from the tumour, through this matrix, to new locations.

In some cancer types the cancer cells use force to ‘elbow’ their way through the matrix. The force is produced by a process similar to muscle contraction. In other types of tumours the tumor-associated healthy cells use force to create tunnels down which the cells move.

The scientists showed that same processes are used to generate force in cancer cells and in the tumor associated normal cells.

Lead author Professor Chris Marshall, a Cancer Research UK-funded scientist from The Institute of Cancer Research, said: “There’s an urgent need to understand how tumors can spread from their site of origin, for example the skin, to other tissues, such as the lungs, liver and bone where the disease becomes more difficult to treat successfully.

“We’ve shown that the same protein called JAK triggers tumour spread via two different routes – it generates the force needed for cancer cells to move around the body and also for triggers healthy cells in tumours to create furrows in tissues down which cancer cells move.

“Encouragingly drugs that block JAK are already in development to stop the growth of tumours. Our new study suggests that such drugs may also stop the spread of cancer.”

Dr. Lesley Walker, Cancer Research UK’s director of cancer information, said: “A huge challenge in successfully treating cancer is stopping it from spreading around the body, and keeping cancer that has already spread at bay. Most deaths from cancer are caused when cancer cells travel to different parts of the body and grow as secondary tumours.

“Discovering how cancer cells can funnel grooves though tissues, to squeeze away from primary tumours and spread to new sites, gives scientists fresh understanding of ways to stop cancer spread - literally in its tracks.”

Provided by Cancer Research UK

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created 10 hours ago | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created 12 hours ago | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created 14 hours ago | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created 17 hours ago | popularity not rated yet | comments 1


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

First study to suggest that the immune system may protect against Alzheimer's changes in humans

Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.